Part 4: The Symptomatic Patient
Dr. Patrick Soon-Shiong, the executive chairman of the Los Angeles Times, discusses the second of three kinds of coronavirus patients: the symptomatic patient. This patient is experiencing flu-like symptoms and perhaps other indications of COVID-19, such as the loss of taste and smell, and should be ready to call a physician or seek hospitalization if symptoms worsen. In this chapter, Soon-Shiong offers an overview of drugs already on the market that are being tested as possible treatments for COVID-19. Soon-Shiong also warns about so-called home remedies and the risks of repurposing existing drugs.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
Soon-Shiong is a surgeon and scientist who has spent his career studying the human immune system to fight cancer and infectious diseases. He is also the chairman and chief executive of NantWorks and the owner of or investor in a number of companies, including ImmunityBio and NantKwest, which are currently researching immunotherapies for COVID-19.
